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Abstract
Background: Cytochrome b5 performs central roles in various biological electron transfer reactions, where
difference in the redox potential of two reactant proteins provides the driving force. Redox potentials of
cytochromes b5 span a very wide range of ~400 mV, in which surface charge and hydrophobicity around the
heme moiety are proposed to have crucial roles based on previous site-directed mutagenesis analyses.
Methods: Effects of mutations at conserved hydrophobic amino acid residues consisting of the heme pocket of
cytochrome b5 were analyzed by EPR and electrochemical methods. Cyclic voltammetry of the heme-binding
domain of human cytochrome b5 (HLMWb5) and its site-directed mutants was conducted using a gold electrode
pre-treated with b-mercarptopropionic acid by inclusion of positively-charged poly-L-lysine. On the other hand,
static midpoint potentials were measured under a similar condition.
Results: Titration of HLMWb5 with poly-L-lysine indicated that half-wave potential up-shifted to -19.5 mV when the
concentration reached to form a complex. On the other hand, midpoint potentials of -3.2 and +16.5 mV were
obtained for HLMWb5 in the absence and presence of poly-L-lysine, respectively, by a spectroscopic
electrochemical titration, suggesting that positive charges introduced by binding of poly-L-lysine around an
exposed heme propionate resulted in a positive shift of the potential. Analyses on the five site-specific mutants
showed a good correlation between the half-wave and the midpoint potentials, in which the former were 16~32
mV more negative than the latter, suggesting that both binding of poly-L-lysine and hydrophobicity around the
heme moiety regulate the overall redox potentials.
Conclusions: Present study showed that simultaneous measurements of the midpoint and the half-wave potentials
could be a good evaluating methodology for the analyses of static and dynamic redox properties of various
hemoproteins including cytochrome b5. The potentials might be modulated by a gross conformational change in the
tertiary structure, by a slight change in the local structure, or by a change in the hydrophobicity around the heme
moiety as found for the interaction with poly-L-lysine. Therefore, the system consisting of cytochrome b5 and its partner
proteins or peptides might be a good paradigm for studying the biological electron transfer reactions.
Background
Cytochromes b can be defined as electron transfer pro-
teins having heme b group(s), noncovalently bound to
the protein. b-Type cytochromes possess a wide range
of properties and functions in a large number of differ-
ent redox processes. Among them, cytochromes b5 are
ubiquitously found in animals, plants, fungi and some
bacteria. The microsomal and mitochondrial (outer
membrane; OM) variants are known and are present in
a membrane-bound form. On the other hand, bacterial
and those from erythrocytes and some animal tissues
are water-soluble (such as for the reduction of
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of N-glycolylneuraminic acid [1]). A membrane-bound
(microsomal) form of cytochrome b5 is required for
numerous biosynthetic and biotransformation reactions,
which include cytochrome P450-dependent reactions
[2], desaturation of fatty acids [3], plasmalogen biosynth-
esis [4], and cholesterol biosynthesis [5,6]. The role of
cytochrome b5 in microsomal P-450-dependent mono-
oxygenase reactions has been studied most extensively
[2]. In addition, a number of fusion enzymes exist in
nature containing cytochrome b5 as a domain compo-
nent. These include mitochondrial flavocytochrome b2
(L-lactate dehydrogenase) [7], sulfite oxidase [8], the Δ
5-
and Δ
6-fatty acid desaturases [9], and yeast inositolpho-
sphorylceramide oxidase [10]. Plant and fungal nitrate
reductases are also cytochrome b5-containing fusion
enzymes [11].
For human cytochrome b5, only a few naturally occur-
ring mutations recognized as a genetic disorder have
been reported. One such example was found by Kurian
et al. [12]. They reported that naturally occurring
human cytochrome b5 T60A mutant [12] displayed an
impaired hydroxylamine reduction capacity. They
observed further that the expressed protein in rabbit
reticulocyte lysate system showed an enhanced suscept-
ibility to the proteolytic degradation. Expression level in
transfected HeLa cells was also significantly lowered.
Another genetically confirmed example was previously
reported. In this case, Steggles et al. identified a homo-
zygous splice site mutation in the CYB5A gene, resulting
in premature truncation of the protein, leading to a very
high methemoglobin concentration in red blood cells of
the patient, being consistent with methemoglobinemia
type IV [13]. The patient exhibited female genitalia at
birth, but, was determined as a male pseudohermaphro-
dite, probably due to the low levels of androgen synth-
esis by the lack of cytochrome b5 activity, which has
been shown to participate in 17a-hydroxylation in adre-
nal steroidogenesis [14].
Whereas more than 300 patients had been reported
with hereditary methemoglobinemia types I or II, only a
few cases of type IV had been reported. Thus, one may
attribute that the rarity of naturally occurring cyto-
chrome b5 mutation may be due to lethality of most
type IV mutations. However, in a very recent study by
employing transgenic mice, Finn et al. found that cyto-
chrome b5 completely null mice were viable, fertile and
produced grossly normal pups at expected Mendelian
ratios [15]. Further, the cytochrome b5 null mice exhib-
ited a number of intriguing phenotypes, including
altered drug metabolism, methemoglobinemia, disrupted
steroid hormone biosynthesis. In addition, the cyto-
chrome b5 null mice displayed skin defects and retarda-
tion of neonatal development. These observations
suggested that cytochrome b5 might play a role control-
ling saturated/unsaturated homeostasis of fatty acids in
higher animals including human.
The membrane-bound form of cytochrome b5 is asso-
ciated with the endoplasmic reticulum. It has a molecu-
lar weight of 16,700 Da and contains about 134 amino
acids in animals (Figure 1A). It is composed of three
domains: a hydrophilic heme-containing catalytic
domain of about 99 amino acids; a membrane-binding
hydrophobic domain containing about 30 amino acids at
the carboxy terminus of the molecule; and a membrane-
targeting region represented by the 10-amino-acid
sequence located at the carboxy-terminus of the mem-
brane-binding domain. Three-dimensional structures of
a number of cytochrome b5 are known [16], but only
for the heme-containing hydrophilic catalytic domain
[17]. Two His residues (His44 and His68) provide the
fifth and sixth heme ligands (Figure 1A, B), and two
propionate groups of the heme b lies at the opening of
the heme-binding pocket, which is formed by highly
conserved hydrophobic amino acid residues (Figure 1A).
The roles of each amino acid were investigated by
detailed site-directed mutagenesis in the past with
employing various structural, spectroscopic and electro-
chemical techniques, including X-ray crystallography
[18-20], NMR [21-23], UV-visible absorption spectro-
scopy, and redox potential measurements [24].
Redox potentials of various forms of cytochrome b5
span a range of ~400 mV. It is well documented that
several factors could regulate and induce changes in the
reduction potential of cytochrome b5 spanning almost
entire range observed. The electrostatic contribution by
surface charges might play important roles in adjusting
the selectivity of the protein-protein interaction. On the
other hand, difference in the redox potential of two
reactant proteins provides the driving force for the elec-
tron transfer reactions. Thus, the clarification of the reg-
ulatory mechanism of the redox potentials might be
essential for the understanding of the biological electron
transfer reactions.
Biological redox potential measurements were usually
conducted either by an equilibrating electrochemical
method or by employing a dynamic cyclic voltammetry.
Common features to all the past voltammetric experi-
ments involving cytochrome b5 and electrodes pre-
treated with various thiol-containing aliphatic acid or
related groups are the large difference between the half-
wave potential (E1/2) and the midpoint potential deter-
mined by the equilibrating method [25]. In the case of
rat OM cytochrome b5, its midpoint potential deter-
mined by the equilibrating method showed as low as
-102 mV; whereas the half-wave potential was found as
+8 mV [25]. Similar large positive shifts were reported
for bovine liver microsomal cytochrome b5 (~+31 mV)
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Figure 1 Alignment of amino acid sequences of cytochrome b5 from various species (A), a close-up view of tertiary structure of
human cytochrome b5 around the heme-pocket with three conserved hydrophobic residues (Leu51, Ala59, and Gly67) and two heme
axial ligands (His44 and His68) indicated (B), a close-up view around the heme pocket with acidic amino acid residues (C).( A) Amino
acid sequences of cytochromes b5 from various species are aligned. Two heme axial ligands (His44 and His68) are indicated by an asterisk (*). On
the other hand, corresponding positions to three target residues (Leu51, Ala59, and Gly67) in the present study are indicated by a cross (+).
Amino acid sequences were obtained from [GenBank; NP_001164735 for rabbit b5, P00170 for horse b5, AAB67610 for rat b5, P56395 for mouse
b5, AAA35729 for human b5, NP_776458 for bovine b5, BAA23735 for human OMb5, AAH72535 for rat OMb5; CAB01732 for C.elegans b5, P40312
for yeast b5, NP_001106739 for silkworm b5]. (B) Human cytochrome b5 NMR solution structure [PDB code: 2I96 model 1] is shown in a ribbon
model with a bound heme b prosthetic group. In addition, three conserved residues (Leu51, Ala59, and Gly67) and two heme axial ligands
(His44 and His68) are indicated. (C) Acidic amino acid residues located on the surface of the heme-binding domain (corresponding to LMWb5)
are indicated.
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mV) [27].
The large positive shift (+110 mV) observed for rat
OM cytochrome b5 were attributed to the binding of
multivalent cations, such as, poly-L-lysine, which were
used for shielding the negatively charged protein surface
and negatively-charged electrode surface to facilitate the
electron transfer [25]. The difference in the potentials
was ascribed, initially, for the binding of multivalent
cations to the specific charged residues on the surface of
cytochrome b5, such as Glu and Asp (Figure 1C) [25],
leading to the modulation of the heme redox potential
differently from that measured by the equilibrating
method. Later, however, a carboxylate of an exposed
heme propionate group and conserved acidic residues
(Glu44, Glu48, Glu56, and Asp60) (Figure 1C) (corre-
sponding to Glu49, Glu53, Glu61, and Asp65, respec-
tively, of human cytochrome b5)w e r ep r o p o s e dt ob e
responsible for the specific binding of multivalent
cations [28]. The formation of such a complex will
result in a neutralization of the charge on the heme pro-
pionate and lowering of the dielectric of the exposed
heme microenvironment by excluding water from the
complex interface. These two factors act synergistically
to destabilize the positive charge of the ferric heme with
respect to the neutral ferrous heme, leading to a positive
shift of the redox potential upon binding of poly-L-
lysine [28,29]. This postulation was partly verified by the
esterification of the heme propionate groups, leading to
the half-wave potential to be independent of the con-
centration of multivalent cations [28,29].
In the present study, we focused on three conserved
hydrophobic amino acid residues (Leu51, Ala59, and
Gly67) consisting of the heme-binding pocket (Figure
1A, B). These residues were not investigated previously
despite of their higher conservation among the various
members of cytochrome b5 protein family (Figure 1A).
Gly67 is located besides the heme axial His residue
(His68) and is near the entrance of the heme-pocket
crevice (Figure 1B). Leu51 and Ala59, on the other
hand, are located in the bottom of the heme pocket
( F i g u r e1 B ) .T h ef o r m e ri so nt h es i d eo fH i s 4 4r e s i d u e ,
the other heme axial ligand. The latter is on the side of
His68 residue. These two residues might be essential for
the stabilization of the heme prosthetic group in the
hydrophobic heme pocket. Therefore, we selected repla-
cing amino acid residues not too hazardous for the
maintenance of the heme cavity. Accordingly, we chose
Thr, Ile, Ala, Ser residues for the replacement of Leu51,
Ala59, and Gly67 residues. We produced and purified
site-directed mutants for these three sites, having parti-
cular interests in the changes of local structure and
hydrophobicity of the heme pocket, which may affect
the redox properties of cytochrome b5.W em e a s u r e d
spectroscopic and electrochemical properties (i.e., redox
potentials were analyzed by an equilibrating method and
a cyclic voltammetry technique) of these mutants to
clarify the structural and electrochemical importance of
the conserved residues.
Methods
Construction of the expression plasmid for wild-type and
site-directed mutants of HLMWb5
The gene coding for a soluble domain (amino acid resi-
dues from Met1 to Leu99; LMWb5) of human cyto-
chrome b5 in pIN3/b5/2E1/OR plasmid [30,31] was
subcloned into pCWori vector as previously described
[32]. Then, the BamH I-Hind III fragment of the pC/
LMWb5 plasmid encoding entire LMWb5 (amino acid
residues from Met1 to Leu99) was inserted into the
BamH I-Hind III site of pBluescript II KS(+) to form a
plasmid pBS/LMWb5 for easier handling upon the site-
directed mutagenesis. The nucleotide sequence of the
pBS/LMWb5 plasmid was confirmed with a DNA
sequencer (PRISM 3100 Genetic Analyzer, ABI).
The site-directed mutagenesis was conducted using
QuikChange Site-Directed Mutagenesis Kit (Stratagene,
La Jolla, CA, USA) according to the manufacturer’s
manual. Following mutagenic primers were used (substi-
tuted codons are underlined): for L51I, L51I-R (5’-
CCAGCTTGTTCCCTGATAACTTCTTCCCCACC-3’)
and L51I-F (5’-GGTGGGGAAGAAGTTATCAGGGAA-
CAAGCTGG-3’); for L51T, L51T-R (5’-CCAGCTT
GTTCCCTTGTAACTTCTTCCCCACC-3’)a n dL 5 1 T - F
(5’-GGTGGGGAAGAAGTTACAAGGGAACAAGCT
GG-3’); for A59V, A59V-R (5’-CCTCAAAGTTCTCAG-
TAACGTCACCTCCAGCTTG-3’) and A59V-F (5’-CAA
GCTGGAGGTGACGTTACTGAGAACTTTGAGG-3’);
for A59 S, A59S-R (5’-CAAGCTGGAGGTGACTC-
TACTGAGAACTTTGAGG-3’)a n dA 5 9 S - F( 5 ’-CA
AGCTGGAGGTGACTCTACTGAGAACTTTGAGG-
3’); for G67A, G67A-R(5’-GGCATCTGTAGAGTGCGC-
GACATCCTCAAAGTTC-3’)a n dG 6 7 A - F( 5 ’-GAAC
TTTGAGGATGTCGCGCACTCTACAGATGCC-3’);
and for G67 S, G67S-R (5’-GGCATCTGTAGAGTGC-
GAGACATCCTCAAAGTTC-3’)a n dG 6 7 S - F( 5 ’-GAA
CTTTGAGGATGTCTCGCACTCTACAGATGCC-3’).
After the site-directed mutagenesis, transformation, and
plasmid preparation, each mutated plasmid (pBS/L51I,
pBS/L51T, pBS/A59V, pBS/A59 S, pBS/G67A, pBS/
G67S) was treated with Nde Ia n dHind III. The each
Nde I-Hind III fragment of pBS/LMWb5 plasmid and
the mutated plasmids was inserted into the Nde I-Hind
III site of pET-28b(+) vector (Novagen, Merck, Darm-
stadt, Germany) to construct pET/HLMWb5, pET/L51I,
pET/L51T, pET/A59V, pET/A59 S, pET/G67A, and
pET/G67 S, respectively, to achieve an efficient expres-
sion and an easier purification of a recombinant protein.
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the upstream of the Nde I-Hind III site and, therefore,
gives an additional extension with a sequence of
MGSSHHHHHHSSGLVPRGSH at the NH2-terminus of
the LMWb5 protein (designated as HLMWb5, hereafter).
Mutations were confirmed with an ABI PRISM 3100
Genetic Analyzer (Applied Biosystems Japan Ltd.) for
both types of plasmids prepared from pBS and pET vec-
tors. Escherichia coli strain BL21(DE3)pLysS was trans-
formed with pET/HLMWb5 (or with one of the mutated
pET plasmids) and was cultivated in low-salt Luria-Ber-
tani (LB) medium containing 30 μg/ml of kanamycin
and 34 μg/ml chloramphenicol at 37°C for pre-culture.
After the pre-culture, HLMWb5 protein (or each
mutant protein) was produced by growing the trans-
formed cells at 37°C in TB medium (12.0 g/L of tryp-
tone, 24.0 g/L yeast extract, 4 ml/L glycerol, 23.1 g/L
KH2PO4, and 125.4 g/L K2HPO4) in the presence of
30 μg/ml of kanamycin and 34 μg/ml of chlorampheni-
col. Induction of the protein expression was achieved by
addition of 200 μM (final) IPTG when the cells had
g r o w nt oa nO . D .o f0 . 6a t6 0 0n m .T h e n ,t h ei n c u b a -
tion temperature was lowered to 26°C. Cells were har-
vested 48 h after the addition of IPTG and were frozen
in liquid nitrogen and stored at -80 °C until use. The
thawed cells were mixed with a lysis buffer (20 mM
Tris-HCl buffer (pH 8.0) containing 0.5 mM EDTA)
and disrupted by the treatment with lysozyme (final,
1m g / m L )a n dD N a s e( f i n a l ,5 0μg/mL) in the presence
of 1 mM of phenylmethylsulfonyl fluoride followed by
sonication on ice with a model 250 sonifier (Branson
Ultrasonic). The disrupted cells were centrifuged at
26,000 g for 20 min at 4 °C. The supernatant was saved
as a crude extract.
Purification of HLMWb5 was conducted as follows.
The crude extract was loaded onto a column of DEAE-
Sepharose CL-6B previously equilibrated with 20 mM
Tris-HCl (pH 8.0) buffer containing 0.5 mM EDTA.
The HLMWb5 was adsorbed in the column as a reddish
band. The column was washed with the same buffer
containing 50 mM NaSCN. The adsorbed LMWb5 was
eluted by a linear gradient of NaSCN concentration
from 50 to 300 mM in the same buffer. Main fractions
were collected based on the SDS-PAGE analysis (12%
gel) and absorbance at 414 nm and were concentrated
to about 5 mL using an Amicon concentrator and a
Millipore membrane (MWCO = 10,000). The concen-
trated HLMWb5 was, then, subjected onto an affinity
column chromatography with Ni-NTA agarose gel
(QIAGEN) previously equilibrated with 50 mM sodium
phosphate buffer (pH 8.0) containing 10 mM imidazole
and 300 mM NaCl. The column was washed with
50 mM sodium-phosphate buffer (pH 8.0) containing
20 mM imidazole and 300 mM NaCl. Finally, adsorbed
HLMWb5 protein was eluted with 50 mM sodium-phos-
phate buffer (pH 8.0) containing 250 mM imidazole and
300 mM NaCl and the eluate was collected. Fractions
that showed a single protein band on SDS-PAGE were
pooled and concentrated, gel-filtrated against 50 mM
sodium phosphate buffer (pH 7.0) with PD-10 mini-
column (Amersham Bioscience). The full-length form of
human cytochrome b5 was purified according to the
procedure as described previously [33]. Concentrations
of purified recombinant proteins were determined spec-
trophotometrically from the absorbance at 423 nm in
the dithionite-reduced form using the extinction coeffi-
cient of 163 mM
-1cm
-1 [34]. The protein concentration
was determined with a modified Lowry method as pre-
viously described [35], in which bovine serum albumin
was used as a standard.
EPR spectroscopy
Oxidized HLMWb5 samples (or mutants in the oxidized
form) in 50 mM potassium-phosphate buffer (pH 7.0)
were concentrated to about 200 ~500 μM with a 50-mL
Amicon concentrator fitted with a membrane filter
(Millipore PTTK04110; pore size MWCO = 10,000). For
HLMWb5 and G67A mutant, concentrated poly-L-lysine
solution (5 mM; Sigma-Aldrich Japan K.K.; mol. wt. =
1,000~4,000; corresponding to 8~30 lysine residues) was
added to make its final concentration as 400 μM. The
samples were introduced into EPR tubes and frozen in
liquid nitrogen (77 K). EPR measurements were carried
out at X-band (9.23 GHz) microwave frequency using a
Varian E-109 EPR spectrometer with 100-kHz field
modulation. An Oxford flow cryostat (ESR-900) was
used for the measurements at 15K. The microwave fre-
quency was calibrated with a microwave frequency
counter (Takeda Riken Co., Ltd., Model TR5212). The
strength of the magnetic field was determined with an
NMR field meter (ECHO Electronics Co., Ltd., Model
EFM 2000AX). The accuracy of the g-values was
approximately +0.01.
Cyclic voltammetry
All electrochemical measurements were done as pre-
viously described [25,32] using a water-jacketed conical
cell that allowed measurements to be made at controlled
temperatures using volumes as small as 150 μL. An ALS
electrochemical analyzer (model 611A) was used for all
measurements. All sample solutions (100 μM, heme
basis, in 50 mM sodium phosphate buffer pH 7.0) were
purged with Ar gas before use and blanketed with Ar
during the electrochemical determinations. For the mea-
surements of the full-length form (1-134 aa) of human
cytochrome b5, 50 mM sodium-phosphate buffer (pH
7.0) containing 0.5% (v/v) Triton X-100 was used as the
buffer. The Au electrode was derivatized with 100 mM
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[25,32]. Poly-L-lysine was added to a final concentration
of 50~300 μM just before the measurements. Concen-
tration of poly-L-lysine solution was calculated assuming
the formal mol. wt. = 4,000. Therefore, actual concen-
tration of poly-L-lysine in the sample solution might be
higher than the indicated values. The average of the
cathodic and anodic peak potentials was taken as the
formal potential. All potentials were measured at 25°C
versus an Ag/AgCl electrode with an internal filling
solution of 3 M KCl saturated with AgCl and are then
converted versus the standard hydrogen potential (SHE).
Spectroscopic redox titrations
Spectroscopic redox titrations were performed essentially
as described by Dutton [36] and Takeuchi [37], using a
Shimadzu UV-2400PC spectrometer equipped with a ther-
mostatted cell holder connected to a low temperature
thermobath (NCB-1200, Tokyo Rikakikai Co, Ltd, Tokyo,
Japan). A custom anaerobic cuvette (1-cm light path, 5-ml
sample volume) equipped with a combined platinum and
Ag/AgCl electrode (6860-10C, Horiba, Tokyo, Japan) and
a screw-capped side arm was used. Purified HLMWb5
sample or its site-specific mutants (final, 15 μM) either in
the presence or absence of poly-L-lysine (200 μM) in
50 mM sodium-phosphate buffer (pH 7.0) was mixed with
redox mediators (anthraquinone-2,6-disulfonate, 20 μM;
1,2-naphthoquinone, 20 μM; phenazine methosulfate, 20
μM; duroquinone, 20 μM; 2-hydroxy-1,4-naphtoquinone,
20 μM; riboflavin, 20 μM). For the redox measurements of
the full-length form of human cytochrome b5,5 0m M
sodium-phosphate buffer (pH 7.0) containing 0.5% (v/v)
Triton X-100 was used as the buffer. The sample was kept
under a flow of moistened Ar gas to exclude dioxygen and
was continuously stirred with a small magnetic stirrer
(CC-301, SCINICS, Tokyo, Japan) inside. Reductive titra-
tion was performed at 25°C by addition of small aliquots
of sodium dithionite (4 or 16 mM) solution through a nee-
dle in the rubber septum on the side arm; for a subsequent
oxidative titration, potassium ferricyanide (4 or 16 mM)
was used as the titrant. In an appropriate interval, visible
absorption spectra and redox potentials were recorded.
The changes in absorbance (A555.0 minus A565.6; the
peak in reduced form minus isosbestic point of HLMWb5)
were corrected considering the dilution effect and ana-
lyzed with Igor Pro (v. 6.03A2) employing a Nernst equa-
tion with a single redox component.
Results
Purification of soluble domain of human cytochrome b5
(HLMWb5) and its mutants
Purification of HLMWb5 and its site-specific mutants
was successful except for L51T mutant. Failure of purifi-
cation for the L51T mutant was due to the inability to
obtain a heme-bound holo-form. We confirmed that
enough amounts of the protein corresponding to
HLMWb5 was produced in E. coli cells upon addition of
IPTG based on the SDS-PAGE analysis and CBB-250
staining. Addition of excess amounts of heme solution
during the disruption of the E. coli cells to reconstitute
the holo-form was unsuccessful, suggesting that the
heme-pocket of the L51T mutant was perturbed signifi-
cantly and not suitable for the accommodation of the
heme prosthetic group, leading to the denatured form.
Thus, we did not pursue the L51T mutant further in
the present study.
Properties of soluble domain of human cytochrome
b5 (HLMWb5) and its mutants
The purified HLMWb5 showed characteristic visible
absorption spectra as a native form of cytochrome b5 by
showing absorption peaks at 413 nm for oxidized form
and at 555, 526, and 423 nm for reduced form (spectra
not shown). Purified HLMWb5 showed a single protein-
staining band (CBB-250 staining) upon SDS-PAGE (12%
gel) analysis with an apparent molecular size of 16.5
kDa. This value was, however, much larger than the
expected value (13548.91 Da) for the NH2-terminal
extension (20 amino acid residues, containing the 6x-
His-tag moiety) plus the soluble domain (1-99 aa) of
human cytochrome b5. To clarify the biochemical nat-
ure of the HLMWb5, we conducted MALDI-TOF-MS
analyses. Untreated HLMWb5 sample showed a single
peak at 13418 m/z corresponding to a mono-protonated
form. A doubly-protonated form showed a weak peak at
6709 m/z. This result suggested that a post-translational
modification (i.e., removal of the initial Met residue)
had occurred in HLMWb5.M A L D I - T O F - M Sa n a l y s e s
on the tryptic peptides of HLMWb5 (data not shown)
proved that the Met residue at the initiation site was
missing. We concluded that the purified HLMWb5 pro-
tein is a form with the sequence corresponding to 2-
119 aa of HLMWb5 (theoretical molecular weight;
13471.72 Da).
All the purified mutants showed very similar UV-visi-
ble absorption spectra with those of HLMWb5, indicat-
ing that those site-specific mutations around the heme-
binding pocket (except for the L51T mutant) did not
affect significantly on the coordination or the electronic
structure of the heme moiety.
EPR spectroscopy of HLMWb5 and its mutants
The EPR spectrum of oxidized HLMWb5 measured at
15K showed gz =3 . 0 3 ,g y =2 . 2 2 ,a n dg x =1 . 4 3( F i g u r e
2A; trace a), very close to those reported for rat [38], rat
outer mitochondrial membrane (OM) [39] and pig [40]
cytochromes b5 and human LMWb5 [32] in which the
6xHis-tag sequence (20 aa) at the NH2-terminal region
Aono et al. Journal of Biomedical Science 2010, 17:90
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Page 6 of 15is not present, or human erythrocyte cytochrome b5
[41]. However, it was slightly different from the report
for the recombinant human erythrocyte cytochrome b5
(gz = 3.06, gy = 2.22, and gx=1 . 4 2 )[ 4 2 ] .I tm u s tb e
noted that there was no high-spin signals around g~6
nor the signals from adventitiously bound non-heme
iron at g = 4.3 in the spectra (spectra not shown) [38].
All the purified mutants showed very similar EPR
spectra to that of HLMWb5 as shown in Figure 2A. Clo-
ser examinations indicated that G67A mutant showed a
slight perturbation on its heme coordination by showing
gz = 3.06 and gy = 2.20, close to the values for house fly
cytochrome b5 [43]. These results confirmed that the
site-specific mutations introduced around the heme-
binding pocket to modulate the hydrophobicity did not
affect significantly on the coordination or the electronic
structure of the heme prosthetic group.
For HLMWb5 and the G67A mutant, effects of the
addition of poly-L-lysine (final concentration, 400 μM)
on the EPR spectrum were examined. However, there
was no apparent shift of their respective g-values (spec-
tra not shown).
Cyclic voltammetry of LMWb5 and its mutants
The Au electrode pre-treated with 3-mercaptopropio-
nic acid gave reversible voltammetric responses for the
HLMWb5 solution but only in the presence of poly-L-
lysine. Without poly-L-lysine, there was no peak cur-
r e n t .A tl e a s t5 0μM of poly-L-lysine was required to
observe a stable peak current (data not shown). In Fig-
ure 3A, a typical voltammogram for HLMWb5 in the
presence of 200 μM of poly-L-lysine is shown. A plot
of the square root of the scan rate vs.p e a kc u r r e n t
(Ipa)( o rI pc, result not shown) was linear for scan rates
up to and greater than 200 mV/sec (Figure 3B), indi-
cating a diffusion-controlled reaction. The half-wave
potential (corresponding to the midpoint potential)
was estimated as -19.5 mV (vs.S H E ) ,w h i c hw a sc l o s e
to the values for the full-length human cytochrome b5
(a)HLMWb5
Magnetic Field (T)
(b)A59V
(c)A59S
(d)G67A
(e)G67S
(f)L51I
0.2 0.3 0.4 0.5
15K
gy=2.22
gy=2.20
gz=3.03
gz=3.04
gz=3.06
Figure 2 X-band EPR spectrum of oxidized HLMWb5 measured
at 15K and effects of the mutations on the spectrum. Following
samples in oxidized form in 50 mM sodium phosphate buffer pH
7.0 were frozen at 77K and their respective EPR spectrum was
measured at 15K. HLMWb5 (trace a, 0.50 mM); A59V (trace b, 0.12
mM); A59 S (trace c, 0.19 mM); G67A (trace d, 0.20 mM); G67 S
(trace e, 0.24 mM), and L51I (trace f, 0.27 mM). Ordinate of each
spectrum was normalized appropriately based on the concentration
for an easier visualization. Other conditions are described in the text.
The signal around g = 2 in G67A mutant (d) was due to a
contaminant from EPR tube.
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Figure 3 Cyclic voltammogram of HLMWb5 in 50 mM sodium
phosphate buffer pH 7.0. (Panel A) The gold electrode was
modified with b-mercaptopropionic acid and the voltammogram of
HLMWb5 (100 μM (final) in 50 mM sodium phosphate buffer pH 7.0)
was obtained in the presence of 200 μM of poly-L-lysine. The
potential shown is vs. an Ag/AgCl reference electrode with an
internal filling solution of 3 M KCl saturated with AgCl (E° = +197
mV vs. SHE). Scan rate = 100 mV/sec. (Panel B) Plot of the anodic
peak current Ipa against the square root of the scan rate ν1/2.
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Page 7 of 15(-20.5 mV) and LMWb5 without the 6xHis-tag moiety
(-21 mV) [32] and for bovine liver cytochrome b5
(-6 mV, -14 mV) [44] measured under similar experi-
mental conditions (Table 1). These results indicated
that presence of 6xHis-tag moiety or COOH-terminal
hydrophobic transmembrane segment does not affect
significantly on the redox properties of the hydrophilic
heme-binding domain of HLMWb5. However, it must
be noted that, in the case of full-length human
cytochrome b5 (-20.5 mV), we observed relatively large
peak separation values and, more significantly, the plot
of the square root of the scan rate vs.p e a kc u r r e n t
was not clearly linear. This might be due to the pre-
sence of detergent Triton X-100 (0.5~1.0%), which
may interfere the smooth diffusion of cytochrome b5
molecules at the electrode surface by forming micelles
with the COOH-terminal hydrophobic segments
incorporated.
Table 1 Half-wave potentials of HLMWb5 and its site-specific mutants in comparison with various animal cytochrome
b5 and their site-specific mutants.
Samples half-wave potential (mV) (vs. SHE) Electrode references
HLMWb5 -19.5 Au* present study
LMWb5 -21 Au* [32]
full-length human cyt. b5 -20.5 Au* present study
L51I -30.5 Au* present study
A59V -29 Au* present study
A59S -31.5 Au* present study
G67A -40.5 Au* present study
G67S -32 Au* present study
human erythrocyte cyt. b5 -9 Au** [42]
rat OM cyt. b5 (soluble domain) +8 Au* [25]
rat OM cyt. b5 (soluble domain) -40 Au*+Mg
2+ [25]
rat OM cyt. b5 (soluble domain) -78 Au*+Cr
3+ [25]
rat OM cyt. b5 (soluble domain) -27 Carbon [28]
DiMe OM cyt. b5 (soluble domain) +20 Carbon [28]
V61L/V45L -14 Carbon [28]
rat OM cyt. b5 (soluble domain) -26 ITO [29]
DiMe OM cyt. b5 (soluble domain) +4 ITO [29]
V61I/V45I -24 ITO [29]
rat liver cyt. b5 (soluble domain) +16.2 Au*
2 [38]
A67V (soluble domain) -2.8 Au*
2 [38]
rat liver cyt. b5 (soluble domain) -7 Au*
3 [47]
bovine liver cyt. b5 (tryptic fragment)
+2 0m MM g
2+ -6 Au*
4 [44]
bovine liver cyt. b5 (tryptic fragment)
+ 20 mM Cr(NH3)6
3+ -14 Au*
4 [44]
bovine liver cyt. b5 (tryptic fragment) -10 Au*
3 [18]
V61E (bovine liver, tryptic) -25 Au*
3 [18]
V61Y (bovine liver, tryptic) -33 Au*
3 [18]
V61H (bovine liver, tryptic) +11 Au*
3 [18]
V61K (bovine liver, tryptic) +17 Au*
3 [18]
V45Y -35 Au*
3 [48]
V45H +8 Au*
3 [48]
V45E -26 Au*
3 [48]
The half-wave potentials (E1/2) were measured from respective cyclic voltammogram using various electrodes pre-treated as indicated.
Au*, gold-electrode modified with b-mercaptopropionic acid + poly-L-lysine (200 μM) carbon, DDAB-modified glassy carbon electrode
ITO, indium-doped tin oxide electrode + poly-L-lysine (200 μM)
Au**, gold-electrode modified with KCTCCA peptide
Au*
2, gold-electrode modified with HO(CH2)4SH
Au*
3, gold-electrode modified with cysteine
Au*
4, gold-electrode modified with HSCH2COOH
Aono et al. Journal of Biomedical Science 2010, 17:90
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Page 8 of 15As noted previously, the voltammetric response of
outer mitochondrial membrane (OM) cytochrome b5
measured by the Au electrode pre-treated with 3-mer-
captopropionic acid (or similar thiol-containing
reagents) were very dependent on the concentration of
multivalent ions in the sample solution [25]. It was pos-
tulated that multivalent cations could bind to the pro-
tein surface and to the electrode surface simultaneously
and allow the negatively charged protein to approach
the negatively charged electrode [25]. This phenomenon
was termed as “ion gating” [45]. Therefore, we con-
ducted detailed analyses concerning the dependency of
half-wave potential (E1/2)o fH L M W b5 on the concen-
tration of poly-L-lysine in a range of 50~300 μM( F i g -
ure 4). Results showed that half-wave potential (E1/2)
shifted in the positive direction as the concentration of
poly-L-lysine increased and, around 200 μMo fp o l y - L -
lysine, it reached a plateau with a value about -20 mV
(Figure 4 line (a)).
Rivera et al. reported that the electron transfer
between the negatively charged electrode and the nega-
tively charged OM cytochrome b5 was promoted by the
addition of Mg
2+ or Ca
2+, instead of poly-L-lysine [25].
However, in the present study, we could not observe
any effects of Mg
2+ or Ca
2+ (~20 mM) to produce a
reversible cyclic voltammogram of HLMWb5;r a t h e ri t
caused a precipitation of the protein in the sample solu-
tion. Therefore, we did not pursue further on the effects
of these cations on the cyclic voltammogram in the pre-
sent study.
We, then, measured the cyclic volatmmogram for the
five site-specific mutants (L51I, A59V, A59 S, G67A,
G67S) in the presence of poly-L-lysine in different con-
centrations (50~300 μM) and the apparent half-wave
potentials (E1/2) were calculated (Figure 4; Table 1).
A typical result for the A59 S mutant is shown in Figure
4 line (b). In this case, half-wave potential shifted posi-
tively as the concentration of poly-L-lysine increased
and, at 200 μM of poly-L-lysine, it reached a plateau as
observed for wild-type HLMWb5 (Figure 4 line (a)). The
maximum value was around -30 mV. Similar concentra-
tion dependency was also observed for the G67 S and
G67A mutants (Figure 4 lines (e) and (f)), although the
G67A mutant showed a significant negative shift in its
half-wave potentials (Figure 4 line (e)). It is noteworthy
that the concentration required to reach a plateau was
around 200 μM in most of the samples measured in the
present study. This value was consistent with the pre-
vious proposal for the formation of the OM cytochrome
b5-poly-L-lysine complex (1:2) [25]. However, for the
L51I and A59V mutants, dependency of the half-wave
potential on the poly-L-lysine concentration was not
observed (Figure 4 lines (c) and (d)). In these two
mutants, the half-wave potential was around -30 mV
irrespective of the concentration of poly-L-lysine (Figure
4 lines (c) and (d)).
Spectroscopic electrochemical titrations of HLMWb5
and its mutants
Spectroscopic redox behavior of HLMWb5 (Figure 5)
showed a good agreement between the points obtained
during reductive and oxidative titrations (Figure 5; solid
circles for the reductive phase and × for the oxidative
phase). The apparent midpoint potentials were esti-
mated to be around 0 mV at pH = 7.0. Least square fit-
ting analysis using the Nernst equation with a single
redox component showed the midpoint potential as -3.2
mV (Figure 5; a solid curve fitted for solid circles), con-
sistent with a previous report on human erythrocyte
cytochrome b5 (-2 mV) determined by a similar method
[46]. We also measured the midpoint potential for the
full-length form of human cytochrome b5 (under an
identical buffer condition but in the presence of 0.5%
(v/v) Triton X-100) and found it as -2.6 mV (data not
shown). This result confirmed that presence of 6xHis-
tag sequence (20 aa) at the NH2-terminal region or
COOH-terminal hydrophobic transmembrane segment
does not affect significantly on the redox properties of
the hydrophilic heme-binding domain of HLMWb5.
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Figure 4 Dependency of the half-wave potential (E1/2)o f
HLMWb5, A59 S, A59V, L51I, G67A, and G67 S mutants on the
concentration of poly-L-lysine. Titration was conducted using the
gold electrode modified with b-mercaptopropionic acid and the
scan rate was maintained at 100 mV/sec. The peak to peak
separation of the cyclic volatmmograms throughout the titration
was around 67 mV. Line (a), HLMWb5 (WT); line (b), A59 S, line (c),
L51I; line (d), A59V; line (e), G67A; line (f), G67 S.
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Page 9 of 15Midpoint potentials of the site-specific mutants were
obtained similarly. The values were tabulated in Table 2.
The lowest value was found for the L51I mutant; but all
the midpoint potentials were found within a relatively
narrow range of 7 mV difference. This fact indicated
that the site-specific mutations introduced in the pre-
sent study did not affect significantly on their static
redox properties.
In the next stage, we examined the effect of addition
of poly-L-lysine (final 200 μM) on the redox potentials
of HLMWb5 and its site-specific mutants determined by
a static equilibrium method. In the case of HLMWb5,
the effect was evident (Figure 5B; solid squares for the
reductive phase and + for the oxidative phase). The
least square fitting analysis using the Nernst equation
with a single redox component showed that the addition
of poly-L-lysine caused a positive shift of its midpoint
potential by ~20 mV (from -3.2 mV to +16.5 mV). Simi-
lar positive shifts of the midpoint potential upon addi-
tion of poly-L-lysine were found for all the samples
examined in the present study including the full-length
cytochrome b5 and five site-specific mutants (Table 2).
It is noteworthy that the shifts were close to +20 mV
except for the G67A mutant.
Discussion
Relative importance and roles of the three conserved
residues
Three conserved hydrophobic amino acid residues
(Leu51, Ala59, and Gly67) consisting of the heme-bind-
ing pocket of cytochrome b5 were not investigated in
the past, despite of their relatively high conservation
among the cytochrome b5 protein family (Figure 1A).
The most significant effect of the mutation was
observed for the L51T mutant, in which the heme-
pocket moiety might be perturbed significantly and
would not be suitable for the accommodation of a heme
prosthetic group, leading to an apo-form (or a dena-
tured form) when expressed in E. coli cells. Introduction
of a hydrophilic Thr residue in the bottom of the hydro-
phobic heme-pocket might be too harsh to maintain the
original native structure, suggesting the critical role of
this hydrophobic residue (Figure 1B). Our computer
modeling study indicated that the L51T mutant would
have a larger cavity in the heme pocket above the heme
plane, being consistent with this view (see Fig. S1(A and
B); additional file 1). On the other hand, introduction of
a Ser (or Ala) residue by replacing Gly67 residue did
not cause such an effect within the heme-pocket, indi-
cating that a hydrophilic residue at the entrance of the
pocket might be tolerable and, therefore, did not cause
significant influences (Figure 1B). Results of the compu-
ter modeling study were consistent with this view (see
Fig. S1(A and C); additional file 1). Ala59 residue resides
in the lowest bottom of the heme pocket. The computer
modeling study indicated that substitution with Ser (or
Val) did not cause any substantial change in the heme
pocket as well. EPR spectra of the oxidized forms of
these mutants (except for the L51T) showed, indeed,
similar spectra with that of HLMWb5 (Figure 2). How-
ever, only for the G67A mutant, its EPR spectrum indi-
cated a slight but distinct perturbation (gz = 3.06, gy =
2.20) (Figure 2), suggesting some important role(s) of
Gly67 residue as an adjacent one to the axial His68 resi-
due. As a whole, these observations indicated that the
three conserved hydrophobic amino acid residues
(Leu51, Ala59, and Gly67) were not particularly
2.5
2.0
1.5
1.0
0.5
0.0
A
b
s
o
r
b
a
n
c
e
700 650 600 550 500 450 400
Wavelength (nm)
HLMWb5 (WT)
100
80
60
40
20
0
R
e
d
u
c
e
d
 
(
%
)
400 200 0 -200
Redox potential (mV)
HLMWb5 (WT)
(A)
(B)
Figure 5 Midpoint potential measurement of HLMWb5 with
spectroelectrochemical titration. Spectroelectrochemical titration
was conducted by recording the absorption spectrum of HLMWb5
(15 μM in 50 mM sodium phosphate buffer pH 7.0) at various redox
potentials by the addition of sodium dithionite to the oxidized form
at 25°C in the presence of various redox mediators (for detail, see
main text). Least-square curve-fitting of the spectroelectrochemical
titration data by using the Nernst equation assuming a single redox
component. Solid circles indicate data points for the reductive
phase and + for the oxidative phase. Other conditions are indicated
in the main text.
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Page 10 of 15important in having direct interactions with the heme
prosthetic group but were very important for maintain-
ing the hydrophobic and structurally-organized environ-
ments around the heme prosthetic group. It might be
noteworthy that naturally occurring human cytochrome
b5 T60A mutant [12] displayed an enhanced susceptibil-
ity to proteolytic degradation, indicating the destabilized
structure around its heme pocket.
Cyclic voltammetry of cytochrome b5
In our present study, we observed a just reverse phe-
nomenon reported for OM cytochrome b5 [25], in
which the half-wave potential was about 110 mV higher
than the midpoint potential determined by the equili-
brating method (Table 1 &2). In our present case, the
half-wave potential of HLMWb5 (-19.5 mV; in the pre-
sence of 200 μM of poly-L-lysine) was about 16 mV
lower than the midpoint potential measured by an equi-
librium method (-3.2 mV) (Table 1 &2), although the
half-wave potential itself showed a positive shift as the
concentration of poly-L-lysine was increased, as found
for OM cytochrome b5 [25], reaching the plateau of
-17.5 mV. A similar redox behavior to our HLMWb5
was reported previously for bovine liver cytochrome b5
Table 2 Midpoint potentials of human and bovine cytochrome b5 and its site-specific mutants.
Samples Midpoint potentials (mV) (vs. SHE) method References
HLMWb5 -3.2 optical titration present study
HLMWb5 + poly-L-lysine (200 μM) +16.5 optical titration present study
human erythrocyte cytochrome b5 -2 optical titration [46]
full-length human cytochrome b5 -2.6 optical titration present study
full-length human cytochrome b5
+ poly-L-lysine (200 μM) +8.7 optical titration present study
L51I -9.5 optical titration present study
L51I + poly-L-lysine (200 μM) +10.5 optical titration present study
A59V -7.7 optical titration present study
A59V + poly-L-lysine (200 μM) +11.7 optical titration present study
A59S -4.9 optical titration present study
A59 S + poly-L-lysine (200 μM) +9.6 optical titration present study
G67A -8.4 optical titration present study
G67A + poly-L-lysine (200 μM) -2.7 optical titration present study
G67S -7.3 optical titration present study
G67S + poly-L-lysine (200 μM) +14.2 optical titration present study
bovine liver cyt. b5 (tryptic fragment) +5.1 OTTLE [49]
bovine liver cyt. b5 (tryptic fragment) -1.8 OTTLE [50]
bovine liver cyt. b5 (tryptic fragment) +5 OTTLE [44]
bovine liver cyt. b5 (tryptic fragment)
+2 0m MM g
2+ +15 OTTLE [44]
bovine liver cyt. b5 (tryptic fragment) +2 OTTLE [24]
F35L -26 OTTLE [24]
F35H -49 OTTLE [24]
F35Y -64 OTTLE [24]
rat OM cyt. b5 (soluble domain) -102 OTTLE [25]
rat OM cyt. b5 (soluble domain)
+ poly-L-lysine (104 μM) -70 OTTLE [28]
rat OM DiMe cyt. b5 (soluble domain) -36 OTTLE [28]
rat OM DiMe cyt. b5 (soluble domain)
+ poly-L-lysine (104 μM) -33 OTTLE [28]
V61L -117 OTTLE [28]
V61L/V45L -148 OTTLE [28]
V61I/V45I -63 OTTLE [29]
Midpoint potentials of human cytochrome b5 (HLMWb5) and its mutants were estimated for the redox titration data obtained in the absence or presence of poly-
L-lysine by a least-square curve fitting using the Nernst equation with assuming a single redox component. For a comparative purpose, midpoint potentials for
the tryptic fragment of bovine liver cytochrome b5 and OM cytochrome b5 obtained by OTTLE method were presented.
OTTLE, optically-transparent-thin-layer-electrode in the presence of Ru(NH3)6 as a mediator
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Page 11 of 15tryptic fragment, in which midpoint potential deter-
mined by the equilibrating method (in the presence of
20 mM Mg
2+) showed +15 mV, whereas the half-wave
potential under a similar condition was -6 mV, leading
to a negative shift of -21 mV (Table 1 &2) [44].
The difference between the half-wave potential and
midpoint potential determined by the equilibrating
method observed for bovine liver cytochrome b5 tryptic
fragment was ascribed to the different surface properties
of the electrodes used [44]. Following the proposal by
Wang et al. [44], our present results can be explained
reasonably. In the cyclic voltammetry, poly-L-lysine
binds simultaneously with the protein moiety and the
carboxy group of b-mercaptopropionic acid on the sur-
face of the electrode. In the spectroscopic equilibrating
method, poly-L-lysine binds only to the protein and the
electron transfer occurs directly between the electrode
and the protein. Therefore, in the cyclic voltammetry, the
interaction of poly-L-lysine with the carboxylates of the
electrode-coated b-mercaptopropionic acid decreased its
effective density of positive charge and, therefore, the
half-wave potential is more negative than those measured
by the spectroscopic equilibrating method. Additionally,
dehydration of the heme edge by excluding water from
the complex interface might also contribute significantly
on the positive shift of the half-wave potential [29].
However, the differences between the half-wave poten-
tial and midpoint potential determined by the equilibrat-
ing method were so much different each other among
OM cytochrome b5, human cytochrome b5,a n db o v i n e
liver cytochrome b5. This fact suggested that the exact
mechanism for determining the redox potential is very
complex. Reality might exist between the two simplified
possibilities. The gross tertiary structures around the
heme moiety would be conserved well among OM cyto-
chrome b5, human cytochrome b5, and bovine liver cyto-
chrome b5 (Figure 1B and 1C) and, therefore, the
distributions of acidic residues on the surface of the
heme domain are also well conserved (Figure 1A and
1C). Therefore, the proposed scheme for the formation
of the complex between OM cytochrome b5 and poly-L-
lysine occurs on the protein surface of HLMWb5 deli-
neated by the exposed heme propionate and correspond-
ing acidic residues (Glu49, Glu53, Glu61, and Asp65) as
well. Therefore, slight conformational differences around
the heme propionate group would be a very important
factor for controlling the heme redox potentials.
Effects of site-specific mutations within the heme pocket
on the cyclic voltammetry
Other factor(s) important for the regulation of heme
redox potential is the hydrophobicity around the heme
pocket [29]. To evaluate such a hydrophobic effect
within the heme pocket on the redox potential, we
produced five site-specific mutants in expecting to have
different modulations on the hydrophobicity. However,
the midpoint potentials for these mutants showed only
slight variations ranging from -5 to -9 mV. This result
might be consistent with the results of our computer
modeling study, which indicated that the site-specific
mutants did not cause any substantial changes in the
heme pocket except for the L51T mutant (see Fig. S1(A
and B); additional file 1).
On the other hand, the half-wave potentials for these
mutants showed a much larger variation (-29~-43 mV)
and a more negative value than that of HLMWb5 (-19.5
mV). More interestingly, the half-wave potentials for
these mutants were categorized into two groups, one
showing clear dependency on the poly-L-lysine concen-
tration (HLMWb5, A59 S, G67A, and G67S), and the
other showing independency on the poly-L-lysine con-
centration (L51I and A59V) (Figure 4). The curvature of
the titration curves for those showing the dependency
on the poly-L-lysine concentration was somewhat simi-
lar each other (Figure 4), indicating a similar mechanism
for controlling the redox potential being operative
within those. Therefore, for these mutants, very similar
interactions between poly-L-lysine and the protein sur-
face of HLMWb5 delineated by the exposed heme pro-
pionate and the acidic residues (Glu49, Glu53, Glu61,
and Asp65) (Figure 1C) might occur, as proposed ori-
ginally for rat OM cytochrome b5. Following this sce-
nario, one may argue that the large variation in the half-
wave potential might be ascribed to the difference in the
dehydration around the heme moiety upon the complex
formation with poly-L-lysine [29]. On the other hand,
the mutants showing an independency on the poly-L-
lysine concentration (i.e. ,L 5 1 Ia n dA 5 9 V )m i g h tb e
reflecting the difference in microenvironment around
the heme propionate group itself caused by the slight
change in the heme cavity structure. Alternatively, since
both Leu51 and Ala59 locate in the bottom of the heme
cavity (Figure 1B), slight conformational change upon
the mutations might propagate to the local negative sur-
face structure around Glu49, Glu53, Glu61, and Asp65
(Figure 1C), resulting in the independency on the poly-
L-lysine concentration. However, our computer model-
ing study did not support any of these possibilities,
indicating the limitation of this kind of modeling study.
One may argue about the cause of the significant nega-
tive shift in the half-wave potential of the G67A mutant
(Figure 4 line (e); Table 1). The likely explanation for the
negative shift would be a change in the hydrophobicity
within the heme-pocket. But we should not exclude the
possibility of a slight structural change caused by the
replacement. Indeed, the G67A mutant showed a distinct
negative value compared to HLMWb5 in the midpoint
potential measurement as well (Table 2). However, the
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reverse of the G67A mutant, actually showed an inter-
mediate value between those of HLMWb5 and the G67A
mutant. Therefore, the significant negative shift would be
caused not only by changes in the hydrophobicity but by
other factors including changes in the heme coordination
(as evidenced by the slight shifts of g-values in its EPR
spectrum) (Figure 2 trace d). Further, the binding mode
of poly-L-lysine itself might be altered due to a slight
change in local negative surface structure, resulting in
lowering of the dehydration effect upon the complex for-
mation at the heme edge [29].
Correlations between the half-wave potential and
midpoint potential
Interestingly, when the midpoint potential measured in
the absence of poly-L-lysine was plotted against the
half-wave potential for each of HLMWb5 and mutants,
there was a good correlation between these two values
(Figure 6 line a), in which the former were always
16~32 mV more positive than the latter. When the mid-
point potential measured in the presence of poly-L-
lysine (200 μM) was plotted against the half-wave poten-
tial similarly, there was a good correlation as well, in
which the midpoint potential values were further up-
shifted by 10~20 mV (Figure 6 line b). This fact sug-
gested that both the binding of poly-L-lysine and the
changes of the hydrophobicity around the heme moiety
(both within the heme-pocket and the exposed heme
edge) regulate the half-wave potential of cytochrome b5
and that the overall redox potentials were modulated by
both factors in similar extents.
Conclusions
Present study showed that simultaneous measurements of
the midpoint potential and the half-wave potential could
be a good evaluating methodology for the analyses of static
and dynamic redox properties of various hemoproteins,
including cytochrome b5, if we took them with an appro-
priate precaution. In the actual biological electron transfer,
the reduction potential of cytochrome b5 might be modu-
lated differently upon the formation of a transient complex
with a partner protein (cytochrome c, hemoglobin, or
cytochrome b5 reductase). The modulations might be
mediated by a gross conformational change in the tertiary
structure, by a slight change(s) in the local structure
including surface charges, or by the change(s) in the
hydrophobicity around the heme moiety (both within the
heme-pocket and the exposed heme edge), as found for
the interaction with poly-L-lysine. Therefore, the system
consisting of cytochrome b5 and its partner protein(s) or
small peptide(s) might be a good paradigm for the study
of biological electron transfer reactions.
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Figure 6 Correlations between the midpoint potential and
half-wave potential (E1/2) for HLMWb5 and its site-specific
mutants. The half-wave potentials (E1/2) were measured at a gold
electrode modified with b-mercaptopropionic acid in the presence
of 200 μM of poly-L-lysine at 25°C as described in the main text.
Midpoint potentials were measured in the absence (line (a))o r
presence (line (b)) of 200 μM of poly-L-lysine as described in the
main text. Lines were drawn to show the correlations assuming a
linear function (f(x) = bx + a). Calculated coefficients and standard
deviations are a = 2.945 ± 3.13, b = 0.2863 ± 0.105 for line (a) (with
Pearson product-moment correlation coefficient = 0.768 and paired
student’s t-test value, **P < 0.01), and a = 26.946 ± 8.17, b =
0.59028 ± 0.274 for line (b) (with Pearson product-moment
correlation coefficient = 0.706 and paired student’s t-test value, **P
< 0.01).
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